DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Emcure Pharmaceuticals Limited — Investor Presentation

NSE 9 hrs ago·6 Aug 2026, 8:26 am

Emcure Pharmaceuticals L

Emcure Pharmaceuticals Limited has submitted an investor presentation to the stock exchanges. This document typically outlines the company's financial performance, strategic initiatives, and future outlook for the upcoming quarters and fiscal year.

For investors, such a presentation is a key source of information. It provides clarity on management's plans and helps assess the company's growth trajectory. Reviewing the data can offer insights into operational efficiency and potential market opportunities.

Investors should focus on the guidance provided for future revenue and profitability. Monitoring the company's response to market trends and its expansion plans will be crucial to understanding its long-term value.